TMDX
TransMedics Group, Inc.
TransMedics Group, Inc. (TMDX) has 12 SEC Form 4 filings (13 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jul 15, 2026.
Insiders have net sold $722K over the trailing 6 months.
- Industry:Medical - Devices
- CEO:Waleed H. Hassanein
- Employees:728
- HQ:Andover, MA, US
- IPO:2019-05-02
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$722K
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$2.7B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Gunderson Thomas J.First filing | Director | Sale | 9,624 | $722K | Jun 17 | SEC ↗ |
Related companies
TransMedics Group, Inc. is in the Healthcare sector.